Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results From the Global Phase 2b Trial of Rademikibart in Patients With Moderate-to-Severe Asthma

SAN DIEGO, CA and TAICANG, China, May 07, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) ("Connect Biopharma" or the "Company"), a global clinical-stage biopharmaceutical

Connect Biopharma May 7 00:00 ET

Sector Update: Health Care Stocks Retreating Late Afternoon

Health care stocks eased in late Wednesday afternoon trading, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each decreasing 0.1%. The iShares Biotechnology ETF (IBB

MT NewswiresApr 17 15:53 ET

Sector Update: Health Care

Health care stocks ease in late Wednesday afternoon trading with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both decreasing 0.1%. The iShares Biotechnology ETF (IBB)

MT NewswiresApr 17 15:32 ET

Connect Biopharma Terminates Agreement on Antiallergic Candidate With Pfizer

Connect Biopharma (CNTB) is terminating its in-license agreement for CBP-174, an antiallergic, with Pfizer (PFE), effective May, to optimize resources and extend its cash runway The company said Tuesd

MT NewswiresApr 17 14:48 ET

Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.

Connect Biopharma Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 17 06:50 ET

Express News | HC Wainwright & Co. Maintains Buy on Connect Biopharma Hldgs, Raises Price Target to $8

Moomoo 24/7Apr 17 06:40 ET